One of the things that I neglected to mention in yesterday’s blog post about priest sexual abuse of minors is the disturbing aspect of the abuse in the Diocese of Pensacola-Tallahassee. Fr. Vijay Godugunuru, a visiting priest from India, was charged and convicted of a sexual offense against a minor. He was ordered deported from the US, his passport was confiscated, but Indian authorities were not notified. In other words, who’s protecting children from this sexual abuser back in India? As far as I know, no one knows about Fr. Vijay and his molestation of a minor in the United States. Children in India should be afforded the same protection as those in the US.

I just completed a three day road trip during which I filed three lawsuits against the Dioceses of Pensacola-‘Tallahassee, St. Augustine, and Orlando. While the venues were dissimilar, the circumstances of each abuse tale were somewhat similar. A priest had ingratiated himself into the lives of devout Catholic families, targeted an unsuspecting minor, and attacked when the child was most vulnerable. One of the tragic cases occurred two years ago while another happened over fifty years ago. The one constant between these two cases remains that lives were shattered, faith lost, and justice was not served.
Priest Abuse Lawyer
Priest Abuse Advocate Attorney

If the FDA is allowed to publish new guidelines for the marketing of off-label drug use, it would be a drug company’s dream come true. Presently, doctors may determine the proper method of prescribing a drug for off label use. However, the pharmaceutical company may not market or promote in any fashion that off-label use. However, the FDA wants to give the drug companies some room to do just that. Luckily, Congressman Henry Waxman (D-CA) doesn’t think that’s such a good idea. Drugs can be dangerous enough without allowing the greedy, hyped-up marketing machine of big-pharma in on the act. Waxman warned the FDA that such approval would “allow drug and device companies to short-circuit FDA review and approval by sponsoring drug trials that are carefully constructed to deliver positive results and then using the results to influence prescribing patterns.” This is a very bad idea. If approved, consumer safety will be at an even greater risk.

Heparin deaths and allergic reactions appear to extend beyond the nine lots disclosed by Baxter a week ago according to a Wall Street Journal Report on Thursday February 14,2008. Heparin is used for a wide variety of medical procedures to prevent clotting such as kidney dialysis and open heart surgery. Baxter did not suspend sales of heparin because it markets about 50% of the heparin on the market and suspension of sales would cause a shortage. This decision was made in consultation with the U.S. Food and Drug Administration. Baxter confirmed to the Wall Street Journal that it gets the active pharmaceutical ingredient for heparin from a Chinese factory that had not been inspected. Our firm is investigating these cases and I expect that we will discover that again the FDA is understaffed and underfunded to protect the public from the danger of poor manufacturing practices in China.

Baxter Healthcare has announced the recall of its blood thinner Heparin. The recall involves 9 lots of the blood thinning drug. The lots involved in the recall are 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074, 107111.
The drugs were manufactured in a Chinese factory that eluded an FDA inspection. The factory was supposed to have had an inspection but, due to human error, the inspection never took place.

Once again, it seems to be the Chinese involved in a consumer product recall. This time, it’s Baxter Healthcare’s Heparin, a blood thinner widely used by patients in this country. The FDA has admitted that the plant should have been inspected, in fact, it was scheduled to be inspected, but it was not inspected. The FDA attributes the non-inspection to human error. This past Monday, the company announced it was suspending production of Heparin because of 350 reactions (including 4 deaths) linked to the drug. 40% of the reactions were considered serious by the FDA. Symptoms include stomach pain, vomiting and diarrhea, low blood pressure, speeding heartbeats and fainting.
Please be sure to visit our Defibrillator Information Website with up To the Minute Sprint Fidelis Lead Class Action Attorney and Medtronic Lawyer Lawsuit news and information regarding the Sprint Fidelis Defibrillator Lead Lawsuit.
Sprint Fidelis Lead Recall Lawyer Page On Our Main Website
http://www.fda.gov/cder/drug/infopage/heparin/heparinQA.htm

Once again, it seems to be the Chinese involved in a consumer product recall. This time, it’s Baxter Healthcare’s Heparin, a blood thinner widely used by patients in this country. The FDA has admitted that the plant should have been inspected, in fact, it was scheduled to be inspected, but it was not inspected. The FDA attributes the non-inspection to human error. This past Monday, the company announced it was suspending production of Heparin because of 350 reactions (including 4 deaths) linked to the drug. 40% of the reactions were considered serious by the FDA. Symptoms include stomach pain, vomiting and diarrhea, low blood pressure, speeding heartbeats and fainting.
Please be sure to visit our Defibrillator Information Website with up To the Minute Sprint Fidelis Lead Class Action Attorney and Medtronic Lawyer Lawsuit news and information regarding the Sprint Fidelis Defibrillator Lead Lawsuit.
Sprint Fidelis Lead Recall Lawyer Page On Our Main Website

Yesterday, I filed a lawsuit against a visiting priest from India and the Diocese of Pensacola-Tallahassee. The priest, Fr. Vijay molested a 15 year old girl two years ago. He was adjudicated guilty and kicked out of the country. However, no one knows if Catholics in Inddia know about this molesting priest. He may be molesting other children.
Today, I’m in Jacksonville preparing to file a sex abuse lawsuit against the Diocese of St. Augustine for the abuse one of its priests, Fr. William Weinheimer, perpetrated against a young boy while he attended St. Mary’s Academy in Jacksonville. The boy’s family kept letters from the priest which intimated sexual abuse. The abuse occurred in the 1950’s but the now adult man still can’t come to grips with the effects of the abuse.

While the preliminary report from the FDA on Botox was careful in discussing the potential dangers of Botox, one thing is clear, the benefits from Botox injections are unclear at best. However, the worst side effects appear to be in children with cerebral palsy. The adverse symptoms associated with Botox are similar to those of botulism, including difficulty swallowing, breathing problems and weakness.

I wish I could say that the priest abuse crisis is over. I wish I could say that institutions like the Catholic Church had made enough changes to stop the awful scourge of the sexual abuse of minors. This week, I’ll be filing three new lawsuits in Florida against Catholic priests and the Dioceses that allowed them to prey on children. Until we have transparency in the Catholic Church the potential for abuse continues.
Priest Abuse Lawyer & Church Abuse Attorney Information On Abuse Advocate Center ( abuseadvocate.com )